Subspecies: clade-171 (HMT-0171) Primary Body Site: Oral
Download Options
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.83 | 1.61 | 0.14 | 0.05 | 0.11 | 0 | 0.05 | 0 | 0 | 0.01 | 0.04 | 0.01 | 0.06 | 0.43 | 0 | 0.52 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.07 | 0.18 | 0.03 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.43 | 0 | 0 | 0 | 0 |
| 90thp | 1.79 | 4.29 | 0.27 | 0.17 | 0.23 | 0 | 0.09 | 0 | 0.01 | 0.01 | 0.05 | 0.04 | 0.01 | 0.43 | 0.01 | 1.26 | 0.01 | 0 |
| Stdev | 0.80 | 2.01 | 0.10 | 0.08 | 0.21 | 0 | 0.05 | 0 | 0.01 | 0.01 | 0.11 | 0.02 | 0.34 | 0 | 0.01 | 1.46 | 0.02 | 0 |
| Prev(%) | 79.17 | 95.70 | 25.00 | 20.00 | 15.79 | 0 | 12.50 | 0 | 0 | 4.02 | 3.08 | 4.35 | 3.33 | 0 | 0 | 12.50 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to A. viscosus and A. sp. HMT 171 were assigned half to each taxon
reads equally close to A. viscosus and A. sp. HMT 171 were assigned half to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 1.09 | 1.20 | 0.01 | 0.07 | 0.02 | 0.04 | 0.10 | 0.01 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.01 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 2.61 | 2.42 | 0.04 | 0.11 | 0.06 | 0.11 | 0.03 | 0.01 | 0 | 0 |
| Stdev | 1.67 | 1.88 | 0.05 | 0.27 | 0.03 | 0.13 | 0.72 | 0.01 | 0.01 | 0 |
| Prev(%) | 89.61 | 93.51 | 20.78 | 57.14 | 46.75 | 49.35 | 23.38 | 22.08 | 10.39 | 1.30 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to A. naeslundii, A. sp. HMT 170, and A. sp. HMT 171 were assigned one-third to each taxon.
Reads equally close to A. naeslundii, A. oris, and A. sp. HMT 169, 170, 171, and 175 were divided equally among taxa.
Reads equally close to A. naeslundii, A. sp. HMT 170, and A. sp. HMT 171 were assigned one-third to each taxon.
Reads equally close to A. naeslundii, A. oris, and A. sp. HMT 169, 170, 171, and 175 were divided equally among taxa.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.56 | 0.67 | 0.03 | 0.13 | 0.03 | 0.03 | 0.02 | 0.02 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.03 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.33 | 1.49 | 0.07 | 0.27 | 0.06 | 0.08 | 0.03 | 0.02 | 0.01 | 0 |
| Stdev | 1.00 | 0.97 | 0.09 | 0.29 | 0.13 | 0.04 | 0.08 | 0.11 | 0.01 | 0 |
| Prev(%) | 97.30 | 97.97 | 47.97 | 83.78 | 75.68 | 79.05 | 52.03 | 42.57 | 33.78 | 2.10 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-171 and HMT-893 were assigned to each taxon in proportion to the abundance of HMT-171 and HMT-893 individually at these sites (SUBP,SUPP).
Reads equidistant to HMT-171 and HMT-893 were assigned to each taxon in proportion to the abundance of HMT-171 and HMT-893 individually at these sites (SUBP,SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.65 | 0.94 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.28 | 2.02 | 0 | 0.10 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 1.38 | 1.63 | 0 | 0.10 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | 0.30 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 90.07 | 90.07 | 0 | 56.16 | 0 | 0 | 0 | 0 | 0 | 24.67 | 0 | 0 | 13.22 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Neither HMT-171 nor HMT-688 were present singularly so these reads were split evenly at this site (RRC).
Because HMT-688 is not present individually, all equidistant reads were assigned to HMT-171 at these sites (SUBP, SUPP).
Neither HMT-171 nor HMT-688 were present singularly so these reads were split evenly at this site (RRC).
Because HMT-688 is not present individually, all equidistant reads were assigned to HMT-171 at these sites (SUBP, SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 1.13 | 1.98 | 0.26 | 0.50 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.07 | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 2.71 | 4.05 | 0.72 | 1.19 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 1.59 | 2.36 | 0.67 | 1.17 | 0 | 0 | 0.38 | 0 | 0 | 0 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 98.03 | 98.05 | 51.11 | 74.94 | 0 | 0 | 32.09 | 0 | 0 | 0 | 0 | 18.21 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
Notes:
Reads equally close to HMT 171 and 175 were assigned half to each taxon.
Reads equally close to HMT 171 and 175 were assigned half to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.80 | 0.73 | 0.01 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.01 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 2.03 | 1.60 | 0.04 | 0.06 | 0.07 | 0.02 | 0.01 | 0.01 | 0 | 0 |
| Stdev | 1.63 | 1.83 | 0.03 | 0.04 | 0.05 | 0.01 | 0.01 | 0.02 | 0 | 0 |
| Prev(%) | 95.95 | 100.00 | 67.44 | 85.71 | 75.00 | 62.00 | 42.42 | 35.48 | 12.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes

